Voyager Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Voyager Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q2 2024.
  • Voyager Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 574 %, a 41.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 574 +169 +41.7% Jun 30, 2024
Q1 2024 521 +246 +89.5% Mar 31, 2024
Q4 2023 609 +437 +254% Dec 31, 2023
Q3 2023 487 +299 +160% Sep 30, 2023
Q2 2023 405 +194 +92.1% Jun 30, 2023
Q1 2023 275 -10.1 -3.55% Mar 31, 2023
Q4 2022 172 -290 -62.8% Dec 31, 2022
Q3 2022 187 -443 -70.3% Sep 30, 2022
Q2 2022 211 -414 -66.2% Jun 30, 2022
Q1 2022 285 -234 -45.1% Mar 31, 2022
Q4 2021 462 +15.3 +3.43% Dec 31, 2021
Q3 2021 630 +227 +56.4% Sep 30, 2021
Q2 2021 625 +236 +60.7% Jun 30, 2021
Q1 2021 519 +101 +24.2% Mar 31, 2021
Q4 2020 447 -24.3 -5.15% Dec 31, 2020
Q3 2020 403 -95.9 -19.2% Sep 30, 2020
Q2 2020 389 -166 -29.9% Jun 30, 2020
Q1 2020 418 -191 -31.3% Mar 31, 2020
Q4 2019 471 -158 -25.1% Dec 31, 2019
Q3 2019 499 -233 -31.8% Sep 30, 2019
Q2 2019 554 -190 -25.5% Jun 30, 2019
Q1 2019 609 -227 -27.2% Mar 31, 2019
Q4 2018 629 -385 -38% Dec 31, 2018
Q3 2018 732 -332 -31.2% Sep 30, 2018
Q2 2018 744 -464 -38.4% Jun 30, 2018
Q1 2018 836 -318 -27.5% Mar 31, 2018
Q4 2017 1.01K -15.8 -1.54% Dec 31, 2017
Q3 2017 1.06K +134 +14.5% Sep 30, 2017
Q2 2017 1.21K +414 +52.2% Jun 30, 2017
Q1 2017 1.15K Mar 31, 2017
Q4 2016 1.03K Dec 31, 2016
Q3 2016 929 Sep 30, 2016
Q2 2016 794 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.